XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
US Stock MarketDetailed Quotes
VRTX Vertex Pharmaceuticals
- 459.000
- -3.580-0.77%
Close Feb 14 16:00 ET
- 459.000
- 0.0000.00%
Post 20:01 ET
117.87BMarket Cap-220.67P/E (TTM)
469.550High457.360Low995.20KVolume462.500Open462.580Pre Close458.34MTurnover0.39%Turnover RatioLossP/E (Static)256.79MShares519.88052wk High7.18P/B117.45BFloat Cap377.85052wk Low--Dividend TTM255.89MShs Float519.880Historical High--Div YieldTTM2.64%Amplitude7.250Historical Low460.547Avg Price1Lot Size
Vertex Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -113.93%-492.6M | 149.19%584.6M | 7.99%1.37B | -430.89%-3.75B | 45.19%1.31B | -14.35%3.54B | -78.25%234.6M | 32.75%1.27B | -0.47%1.13B | -5.89%899.9M |
| Net income from continuing operations | -114.80%-535.6M | -5.76%913M | 0.98%1.05B | -492.44%-3.59B | 57.13%1.1B | 8.96%3.62B | 18.31%968.8M | 11.26%1.04B | 12.98%915.7M | -8.17%699.8M |
| Operating gains losses | 9,516.67%57.7M | 1,700.00%7.2M | 74.19%10.8M | 3,075.00%12.7M | 521.88%27M | -99.60%600K | -93.33%400K | 137.13%6.2M | -99.52%400K | -108.47%-6.4M |
| Depreciation and amortization | 14.29%207.2M | -21.19%46.5M | 26.37%53.2M | 30.43%54M | 37.89%53.5M | 22.25%181.3M | 53.65%59M | 14.71%42.1M | 10.99%41.4M | 8.08%38.8M |
| Deferred tax | 34.99%-348.8M | 139.39%51.6M | -6.75%-123.3M | 32.73%-118.8M | -39.59%-158.3M | -94.45%-536.5M | -188.45%-131M | 36.64%-115.5M | 23.02%-176.6M | -821.95%-113.4M |
| Other non cash items | -31.48%-56.8M | -27.86%-41.3M | 313.33%41.6M | -84.82%-20.7M | -283.84%-36.4M | 5.47%-43.2M | -169.61%-32.3M | 32.99%-19.5M | 81.46%-11.2M | 861.54%19.8M |
| Change In working capital | -93.75%-514.8M | 33.22%-560.2M | -16.62%157.5M | -198.37%-241.4M | -6.91%129.3M | -177.96%-265.7M | -822.88%-838.9M | 133.79%188.9M | -36.04%245.4M | 523.48%138.9M |
| -Change in receivables | -18.07%-99.3M | 348.05%69M | -749.18%-51.8M | 4,758.62%135.1M | -178.01%-251.6M | 76.55%-84.1M | 50.98%15.4M | 94.90%-6.1M | 96.55%-2.9M | 45.22%-90.5M |
| -Change in inventory | -60.20%-517.3M | -110.71%-147.5M | -87.18%-182.5M | -47.25%-107.2M | 3.03%-80.1M | -136.73%-322.9M | 10.60%-70M | -263.81%-97.5M | -118.62%-72.8M | -4,230.00%-82.6M |
| -Change in prepaid assets | 63.29%-200.3M | 63.53%-164.6M | 117.36%21M | -695.41%-155.9M | 114.72%99.2M | -67.19%-545.7M | -58.63%-451.3M | 4.87%-121M | -210.73%-19.6M | -31.66%46.2M |
| -Change in payables and accrued expense | -45.12%262.4M | 19.77%-311.7M | -37.36%236.7M | -54.15%143.2M | 10.09%194.2M | -27.92%478.1M | -39.80%-388.5M | 4.02%377.9M | -41.16%312.3M | 274.52%176.4M |
| -Change in other current liabilities | -81.00%39.7M | -109.73%-5.4M | 276.69%134.1M | -1,003.52%-256.6M | 87.47%167.6M | -58.13%208.9M | -89.71%55.5M | 495.56%35.6M | 159.92%28.4M | 469.43%89.4M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -113.93%-492.6M | 149.19%584.6M | 7.99%1.37B | -430.89%-3.75B | 45.19%1.31B | -14.35%3.54B | -78.25%234.6M | 32.75%1.27B | -0.47%1.13B | -5.89%899.9M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -20.00%-3.77B | 7.29%-821.9M | -195.67%-348M | -52.58%-463.7M | -16.51%-2.14B | -878.42%-3.14B | -604.84%-886.5M | 69.36%-117.7M | -394.15%-303.9M | -3,495.29%-1.83B |
| Net PPE purchase and sale | -48.55%-297.7M | -59.38%-92.6M | -66.75%-67.7M | -15.77%-69M | -62.47%-68.4M | 2.10%-200.4M | -72.92%-58.1M | 25.09%-40.6M | -11.82%-59.6M | 33.81%-42.1M |
| Net intangibles purchase and sale | -223.62%-187.7M | --0 | --0 | ---7.7M | ---180M | ---58M | ---58M | --0 | --0 | --0 |
| Net business purchase and sale | --0 | --258M | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Net investment purchase and sale | -13.26%-3.23B | -24.14%-956.4M | 81.32%-14.2M | -73.51%-372M | -5.39%-1.89B | -1,354.86%-2.85B | -399.77%-770.4M | -122.87%-76M | -2,514.63%-214.4M | -14,318.25%-1.79B |
| Net other investing changes | -74.19%-54M | ---30.9M | -636.36%-8.1M | ---- | ---- | 35.15%-31M | --0 | ---1.1M | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -20.00%-3.77B | 7.29%-821.9M | -195.67%-348M | -52.58%-463.7M | -16.51%-2.14B | -878.42%-3.14B | -604.84%-886.5M | 69.36%-117.7M | -394.15%-303.9M | -3,495.29%-1.83B |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -165.90%-1.49B | -226.63%-391.3M | -134.85%-387.5M | -2,172.83%-358.6M | -21.31%-357.5M | -730.43%-562.2M | -398.01%-119.8M | -174.09%-165M | -63.73%17.3M | -208.91%-294.7M |
| Net issuance payments of debt | 25.17%-33.6M | 89.17%-1.3M | 52.21%-5.4M | -24.55%-13.7M | -24.53%-13.2M | 47.49%-44.9M | -15.38%-12M | 77.17%-11.3M | 13.39%-11M | 17.83%-10.6M |
| Net common stock issuance | -142.02%-1.58B | -178.45%-425.2M | -129.96%-391.4M | -1,176.43%-400.8M | -21.81%-364.7M | -280.06%-653.7M | -7,171.43%-152.7M | -254.58%-170.2M | -613.64%-31.4M | -154.81%-299.4M |
| Proceeds from stock option exercised by employees | -14.86%114.6M | -26.08%34.3M | -45.45%8.4M | -6.14%55M | 19.01%16.9M | -27.75%134.6M | -10.08%46.4M | -57.92%15.4M | -9.01%58.6M | -57.86%14.2M |
| Net other financing activities | 244.44%6.2M | 160.00%900K | -18.18%900K | -18.18%900K | 218.18%3.5M | -48.57%1.8M | -236.36%-1.5M | 57.14%1.1M | 175.00%1.1M | -15.38%1.1M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -165.90%-1.49B | -226.63%-391.3M | -134.85%-387.5M | -2,172.83%-358.6M | -21.31%-357.5M | -730.43%-562.2M | -398.01%-119.8M | -174.09%-165M | -63.73%17.3M | -208.91%-294.7M |
| Net cash flow | ||||||||||
| Beginning cash position | -1.33%10.37B | -52.79%5.25B | -54.78%4.59B | -1.36%9.17B | -1.33%10.37B | 54.59%10.51B | 21.14%11.12B | 16.65%10.15B | 22.25%9.3B | 54.59%10.51B |
| Current changes in cash | -3,355.88%-5.76B | 18.54%-628.6M | -35.65%634.3M | -639.74%-4.58B | 3.35%-1.19B | -104.45%-166.6M | -159.63%-771.7M | 92.86%985.7M | -24.71%847.8M | -251.69%-1.23B |
| Effect of exchange rate changes | -258.36%-42.6M | -272.63%-47.3M | 201.33%22.8M | -125.00%-2.5M | -230.00%-15.6M | 192.12%26.9M | -32.84%27.4M | 41.10%-22.5M | 138.61%10M | 303.39%12M |
| End cash Position | -55.92%4.57B | -55.92%4.57B | -52.79%5.25B | -54.78%4.59B | -1.36%9.17B | -1.33%10.37B | -1.33%10.37B | 21.14%11.12B | 16.65%10.15B | 22.25%9.3B |
| Free cash flow | -129.83%-978M | 315.19%492M | 6.05%1.3B | -456.37%-3.83B | 23.36%1.06B | -16.47%3.28B | -88.66%118.5M | 36.23%1.23B | -1.08%1.07B | -3.90%857.8M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Trending Stocks
Discussing
Big Tech’s earnings season in full swing! Nvidia is the only one left
On Thursday, $Amazon (AMZN.US)$ stock fell after the firm reported Q4 adjusted earnings of $1.86/share, vs estimates of $1.50/share, on reve
Moo Earnings
Feb 2 12:39
AMZN earnings preview: Grab rewards by guessing the opening price!